These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
779 related items for PubMed ID: 19433462
1. The frequency of anti-beta2-glycoprotein I antibodies is low and these antibodies are associated with pulmonary hypertension in mixed connective tissue disease. Hasegawa EM, Caleiro MT, Fuller R, Carvalho JF. Lupus; 2009 Jun; 18(7):618-21. PubMed ID: 19433462 [Abstract] [Full Text] [Related]
2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR. J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [Abstract] [Full Text] [Related]
3. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome. Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A. Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458 [Abstract] [Full Text] [Related]
4. Lupus anticoagulant, high levels of anticardiolipin, and anti-beta2-glycoprotein I antibodies are associated with chronic thromboembolic pulmonary hypertension. Martinuzzo ME, Pombo G, Forastiero RR, Cerrato GS, Colorio CC, Carreras LO. J Rheumatol; 1998 Jul; 25(7):1313-9. PubMed ID: 9676762 [Abstract] [Full Text] [Related]
5. Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis. Marie I, Jouen F, Hellot MF, Levesque H. Br J Dermatol; 2008 Jan; 158(1):141-4. PubMed ID: 18028496 [Abstract] [Full Text] [Related]
6. IgG anti-beta2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus: prevalence and diagnostic value for the antiphospholipid syndrome. Tubach F, Hayem G, Marchand JL, Weber M, Palazzo E, de Bandt M, Roux S, Kahn MF, Meyer O. J Rheumatol; 2000 Jun; 27(6):1437-43. PubMed ID: 10852267 [Abstract] [Full Text] [Related]
7. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa. Kawakami T, Yamazaki M, Mizoguchi M, Soma Y. Arthritis Rheum; 2007 Dec 15; 57(8):1507-13. PubMed ID: 18050170 [Abstract] [Full Text] [Related]
8. Accuracy of the first fully automated method for anti-cardiolipin and anti-beta2 glycoprotein I antibody detection for the diagnosis of antiphospholipid syndrome. Villalta D, Alessio MG, Tampoia M, Da Re A, Stella S, Da Re M, Tozzoli R, Bizzaro N. Ann N Y Acad Sci; 2009 Sep 15; 1173():21-7. PubMed ID: 19758127 [Abstract] [Full Text] [Related]
9. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus. Sahin M, Duzgun N, Tunc SE, Tutkak H. Clin Biochem; 2007 May 15; 40(8):526-30. PubMed ID: 17359958 [Abstract] [Full Text] [Related]
10. Antiphospholipid antibody tests: spreading the net. Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, Khamashta MA. Ann Rheum Dis; 2005 Nov 15; 64(11):1639-43. PubMed ID: 15817655 [Abstract] [Full Text] [Related]
11. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review. Bruce IN, Clark-Soloninka CA, Spitzer KA, Gladman DD, Urowitz MB, Laskin CA. J Rheumatol; 2000 Dec 15; 27(12):2833-7. PubMed ID: 11128672 [Abstract] [Full Text] [Related]
12. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease. Komatireddy GR, Wang GS, Sharp GC, Hoffman RW. J Rheumatol; 1997 Feb 15; 24(2):319-22. PubMed ID: 9034990 [Abstract] [Full Text] [Related]
13. Study of anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with ischemic stroke. Cojocaru IM, Cojocaru M, Muşuroi C, Botezat M. Rom J Intern Med; 2003 Feb 15; 41(2):189-204. PubMed ID: 15526503 [Abstract] [Full Text] [Related]
14. [Antibodies to beta2-glycoprotein I in systemic lupus erythematosus: new laboratory marker of antiphospholipid syndrome]. Reshetniak TM, Derksen RV, Alekberova ZS, Horbach D, De Groot F, Nasonov EL, Kalashnikova LA, Match ES, Nasonova VA. Klin Med (Mosk); 1998 Feb 15; 76(3):36-40. PubMed ID: 9575746 [Abstract] [Full Text] [Related]
15. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus. Danowski A, Kickler TS, Petri M. J Rheumatol; 2006 Sep 15; 33(9):1775-9. PubMed ID: 16960938 [Abstract] [Full Text] [Related]
16. Clinical significance of anticardiolipin and anti-beta2-glycoprotein I antibodies. Obermoser G, Bitterlich W, Kunz F, Sepp NT. Int Arch Allergy Immunol; 2004 Oct 15; 135(2):148-53. PubMed ID: 15345914 [Abstract] [Full Text] [Related]
17. Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma. Bairey O, Blickstein D, Monselise Y, Lahav J, Stark P, Prokocimer M, Nativ HM, Kirgner I, Pazgal I, Shaklai M. Eur J Haematol; 2006 May 15; 76(5):384-91. PubMed ID: 16466368 [Abstract] [Full Text] [Related]
18. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis. Musial J, Swadzba J, Motyl A, Iwaniec T. J Rheumatol; 2003 Apr 15; 30(4):723-30. PubMed ID: 12672190 [Abstract] [Full Text] [Related]
19. Anti-beta(2)-glycoprotein I autoantibody expression as a potential biomarker for strokes in patients with anti-phospholipid syndrome. Ali HY, Abdullah ZA. J Immunotoxicol; 2008 Apr 15; 5(2):173-7. PubMed ID: 18569388 [Abstract] [Full Text] [Related]